Drugs / PD-217,014
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00159640 | Feb 2004 → ? | — | Pfizer | Terminated | No outcome recorded |
| Phase 2 | NCT00139672 | Jan 2004 → Feb 2005 | irritable bowel syndrome | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PD-217,014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00139672 ↗ |
| Modality | Small molecule | — CHEMBL4297414 ↗ |